✦ LIBER ✦

A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans

✍ Scribed by Joseph A. Jakubowski; Nobuko Matsushima; Fumitoshi Asai; Hideo Naganuma; John T. Brandt; Takashi Hirota; Stephen Freestone; Kenneth J. Winters

Book ID: 111754379
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 228 KB
Volume: 63
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2006.02792.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet inhibitory activity and pharmac

Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y 12 inhibitor: A multiple-dose study in healthy humans†

✍ Matsushima, Nobuko; Jakubowski, Joseph A.; Asai, Fumitoshi; Naganuma, Hideo; Bra 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 139 KB

Platelet inhibitory activity and pharmac

Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y 12 inhibitor: A single ascending dose study in healthy humans†

✍ Asai, Fumitoshi; Jakubowski, Joseph A.; Naganuma, Hideo; Brandt, John T.; Matsus 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 189 KB

Stereoselective inhibition of human plat

Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (Prasugrel, LY640315), a novel P2Y12 receptor inhibitor

✍ Hasegawa, Michihiro; Sugidachi, Atsuhiro; Ogawa, Taketoshi; Isobe, Takashi; Jaku 📂 Article 📅 2005 🏛 Schattauer 🌐 English ⚖ 277 KB